Nisa Investment Advisors LLC Trims Position in Option Care Health, Inc. (NASDAQ:OPCH)

Nisa Investment Advisors LLC decreased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 13.1% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 12,765 shares of the company’s stock after selling 1,924 shares during the period. Nisa Investment Advisors LLC’s holdings in Option Care Health were worth $430,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Financial Management Professionals Inc. purchased a new position in shares of Option Care Health during the third quarter valued at approximately $29,000. First Horizon Advisors Inc. purchased a new position in Option Care Health during the third quarter worth approximately $37,000. Advisors Asset Management Inc. raised its stake in Option Care Health by 121.4% during the first quarter. Advisors Asset Management Inc. now owns 1,337 shares of the company’s stock worth $42,000 after purchasing an additional 733 shares during the period. NewEdge Advisors LLC raised its stake in Option Care Health by 1,031.9% during the first quarter. NewEdge Advisors LLC now owns 1,562 shares of the company’s stock worth $50,000 after purchasing an additional 1,424 shares during the period. Finally, Headlands Technologies LLC raised its stake in Option Care Health by 5,796.7% during the third quarter. Headlands Technologies LLC now owns 1,769 shares of the company’s stock worth $57,000 after purchasing an additional 1,739 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

OPCH has been the topic of a number of recent analyst reports. Barrington Research increased their price target on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “outperform” rating in a research note on Friday, February 23rd. Jefferies Financial Group increased their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research note on Monday, March 4th.

Option Care Health Price Performance

Option Care Health stock opened at $30.27 on Thursday. Option Care Health, Inc. has a 52-week low of $24.23 and a 52-week high of $35.74. The firm has a fifty day moving average of $32.34 and a 200-day moving average of $31.59. The firm has a market capitalization of $5.26 billion, a P/E ratio of 20.59, a PEG ratio of 1.76 and a beta of 1.22. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Thursday, February 22nd. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.03. Option Care Health had a net margin of 6.21% and a return on equity of 18.78%. The company had revenue of $1.12 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same quarter in the prior year, the business earned $0.26 earnings per share. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. As a group, analysts predict that Option Care Health, Inc. will post 1.13 EPS for the current year.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the company’s stock in a transaction dated Monday, February 26th. The stock was bought at an average price of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the transaction, the director now directly owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.